A new medical lab in Lake Nona will help in the effort to expand treatment and trials for cancer research.
The biotech company behind the lab, Protean BioDiagnostics, moved there in January.
The company will hire between 12 and 15 people in the next two years. It already employs about a dozen in multiple sites, including one in Canada.
Protean chose Lake Nona because of its strong presence in biotech, CEO Dr. Anthony Magliocco said in a news release.
“We looked around the state, and this was by far the best space to grow. Lake Nona’s medical city aligns with what we want to do now and into the future,” he said.
They include medical lab techs, scientists and artificial intelligence experts.
“This is a company that will be on the forefront of Central Florida’s biosciences industry for years to come,” said Carol Ann Dykes Logue, a director of UCF’s business incubation program. “They have a great foundation with significant contracts to truly make a difference in people’s lives.”
Protean works with biotech and pharma companies on diagnostics and cancer screening tests.
The company hopes its tech will increase the availability of precision oncology treatments, or treatments specifically designed for a patient.
Presently, about 5-10 percent of cancer patients can access it, Magliocco said.
“Furthermore, managing all the new information about therapies and trials today is overwhelming for most oncologists, so we take that pressure off them to make recommendations for their patients.”
WANT TO HELP OTN TELL ORLANDO’S TECH STORY? THEN USE THE LINKS BELOW TO SHARE ON ON SOCIAL MEDIA.
Also, be sure to catch us on social media below!